• flag
    • flag
    • flag
    • flag
    • flag
    • flag
    • flag
    • flag
  • Have a question? Call us: 
    +1 (800) 472-4508
    Tradeshow

    Pharmapack

    DATE:
    January 22, 2025
    through
    January 23, 2025
    LOCATION:
    Porte de Versailles – Hall 7.2
    Paris, France
    BOOTH:
    Stephanie Wojdyla
    [email protected]

    We’re excited to announce that Sterigenics will be exhibiting together with our sister company Nelson Labs at Pharmapack in Paris, France on January 22 – 23, 2025. Pharmapack is the leading event for pharma professionals in Paris, featuring exhibitors, content sessions and networking opportunities. Visit us at booth D47 – Hall 7.2 and our Sotera Health experts will be available to discuss your sterilization and lab testing needs.

    Please plan on joining our Learning Labs expert presentation featuring Jean-François Zeevaert, Principal Scientist, Sterigenics.

    Ensuring the Safety and Integrity of Connected Diabetic Devices: Navigating Regulatory, Sterilization, and Testing Challenges.

    Thursday, January 23, 2025 3:10 PM to 3:40 PM · 30 min. (Europe/Paris)
    Learning Lab Theatre L20

    Connected devices such as Continuous Glucose Monitoring (CGM) devices are essential for effective diabetes management, offering real-time glucose data to patients and healthcare providers. However, each stage of the connected device lifecycle, from design to commercialization, presents unique challenges in maintaining sterility, safety, and regulatory compliance. In this presentation, Jean-François (Jeff) Zeevaert, Principal Scientist Gas Sterilization at Sterigenics, will outline critical challenges that manufacturers must address: Device Complexity, Residual Management, Safety Testing, Cybersecurity, Regulatory Compliance, and Sterilization. Jeff will then dive deeper into sterilization considerations, covering key aspects such as, feasibility, residue management and stored energy (eg, battery). With CGM sensors in direct contact with body fluids, proper sterilization is vital to ensure patient safety without compromising device functionality. By understanding and addressing these challenges early in the design and development process, manufacturers can improve device performance, ensure compliance, and ultimately enhance patient outcomes.

    For more information, please visit: www.pharmapackeurope.com